Abstract:Background: Hepatitis Be antigen (HBeAg) precursor proteins, which share an identical encoding PreC/C open reading frame (PreC/C-ORF) of hepatitis B virus (HBV) core, can inhibit viral replication in vitro. The apolipoprotein B mRNA (messenger ribonucleic acid) editing enzyme catalytic polypeptide 3A (APOBEC3A) can inhibit HBV replication by interacting with the HBV core protein. The aim of the study was to explore whether the HBeAg precursor proteins can regulate HBV replication by interacting with APOBEC3A.Methods: Plasmids harboring the coding sequence of HBeAg precursor proteins (P25 and P22) and APOBEC3A were individu-ally or co-transfected into human hepatoma and embryonic kidney cells. P25, P22, and APOBEC3A expressions were quantified by Western blotting. The co-localization and interaction of P25, P22, and APOBEC3A were determined by confocal microscopy and co-immunoprecipitation (Co-IP). We constructed serial precursor proteins of HBeAg deletion mutants for further Co-IP analysis. Enzyme-linked immunosorbent assay (ELISA) was employed to evaluate the levels of HBeAg and HBsAg. HBV repli-cation intermediates from the transfected cells were detected by Southern blotting.Results: P25, P22, and APOBEC3A proteins were successfully expressed in transfected cells, and P25 or P22 protein co-localization with APOBEC3A protein in the cytoplass. Co-IP with APOBEC3A was mediated by the central region of the HBeAg precursor (amino acids 107-178). The levels of HBsAg were significantly lower in cells co-transfected with HBV e-, P22/P25, and APOBEC3A, than in cells co-transfected with HBV e-, APOBEC3A, or in cells co-transfected with HBV e-, P22/P25. The levels of HBeAg were lower in cells co-transfected with HBV e-, P22/P25, and APOBEC3A, than in cells co-transfected with HBV e-, P22/P25. Compare with cells transfected with HBV e-, APOBEC3A, or in cells co-transfected with HBV e-, P25/P22, HBV replication intermediates were lower in the cells co-transfected with HBV e-, P25, APOBEC3A, and significantly lower in the cells with HBV e-, P22, APOBEC3A.Conclusions: HBV replication can be inhibited by the interaction of P25/P22 with APOBEC3A protein in the cytoplasm.

APOBEC3G Directly Binds Hepatitis B Virus Core Protein in Cell and Cell Free Systems

Inhibition of Hepatitis B Virus Replication by APOBEC3G in Vitro and in Vivo.

Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.

N-terminal and C-terminal Cytosine Deaminase Domain of APOBEC3G Inhibit Hepatitis B Virus Replication

Host APOBEC3G Protein Inhibits HCV Replication Through Direct Binding at NS3.

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

HBeAg Precursor Proteins Interact with APOBEC3A and Inhibit HBV Replication

Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G

Core-Apobec3c Chimerical Protein Inhibits Hepatitis B Virus Replication

Host Apolipoprotein B Messenger RNA-editing Enzyme Catalytic Polypeptide-Like 3G is an Innate Defensive Factor and Drug Target Against Hepatitis C Virus

The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function During Viral Replication

Construction of Eukaryotic Expressional Vectors of APOBEC3G and the Effects on the Replication and Expression of HBV

Young Investigator Session

Human APOBEC3F Incorporation into Human Immunodeficiency Virus Type 1 Particles.

DHX9 Interacts with APOBEC3B and Attenuates the Anti-Hbv Effect of APOBEC3B

Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis

Cloning and Eukaryotic Expression of APOBEC3F and Its Anti-HBV Effect

Cell-specific Regulation of APOBEC3F by Interferons

APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (−)-DNA

Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

[Expression and Subcellular Localization of APOBEC3G in Peripheral Blood Mononuclear Cells and Liver Tissues of Chronic HBV Patients].